Skip to content

Pilot study to assess risk factors and complications in interventional ultrasound (INVUS)

Pilot study to assess risk factors and complications in interventional ultrasound (INVUS) - Pilot study INVUS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025973
Enrollment
12
Registered
2021-08-31
Start date
2021-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interventionell Ultrasound

Interventions

Group 1: prospective observational study of ultrasound-guided abdominal interventions in adults

Sponsors

Medizinische Hochschule Brandenburg Theodor FontaneBrandenburgisches Institut Klinischer Ultraschall (BIKUS)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study will include diagnostic and/or therapeutic interventions under continuous ultrasound imaging percutaneously or transcavitary (endosonographic) in the abdomen and/or retroperitoneum in patients aged eighteen years and older. Including simple punctures for fluid or tissue removal up to more complex drainage therapies as well as ablation and sclerotherapy procedures.

Exclusion criteria

Exclusion criteria: Diagnostic or therapeutic ascites punctures, procedures in the prostate region and outside the abdomen, e.g. on the thorax (including the mediastinum) or on the extremities and joints, should not be included. Lack of patient consent to participate in the study. Children and adolescents not completed 18 years of age.

Design outcomes

Primary

MeasureTime frame
The study objective is to test a web-based documentation system for the collection of routine data related to ultrasound-assisted procedures and to evaluate the selected collection parameters for analyzability with respect to the following endpoints: 1. frequency of immediate complications (e.g., bleeding) and late complications (especially infections), overall morbidity and mortality. 2. predictors of inadequate intervention outcomes and of complications 3. effectiveness of measures for complication prevention 4. frequency, range of methods and effectiveness of the use of INVUS for the treatment of abscesses.

Countries

Germany

Contacts

Public ContactNicole Eder

Krankenhaus Märkisch-Oderland GmbH

nicole.eder@mhb-fontane.de033415222350

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026